Personalized lifetime prediction of survival and treatment benefit in patients with HFrEF: The LIFE-HF model

A really interesting new paper is online in the European Society of Cardiology Journals #EurJHF with involvement from the University of Glasgow Heart Failure Research Group team

onlinelibrary.wiley.com/doi/10.1002/ej…

In #HFrEF , adding mineralocorticoid antagonists was always beneficial, and most beneficial the longer patients used them, a new #JACC study suggests: bit.ly/3PvPzEk

#CardioTwitter University of Glasgow Heart Failure Research Group Pardeep S Jhund

New paper online now in JACC Journals describing the association between CA125 and outcomes along with the effect of dapagliflozin in ambulatory HFrEF.

sciencedirect.com/science/articl…

Some commentary on the article here from TCTMD: tctmd.com/news/congestio…

Lots of recent publications from the group University of Glasgow Heart Failure Research Group to catch up on!

A select few are highlighted below - for a full up-to-date list of publications from the group go to bit.ly/UoG_HF_research

Fantastic paper now online in #EurHeartJournal led by Jawad Haider Butt MD

Urinary cGMP/BNP ratio, sacubitril/valsartan, and outcomes in heart failure with reduced ejection fraction: An Analysis of the PARADIGM-HF trial Jawad Haider Butt MD University of Glasgow Heart Failure Research Group #AHAJournals ahajrnls.org/3Jrubxg

Fantastic to see so much of the work from the University of Glasgow Heart Failure Research Group team included in this Top 10 review of 2022 in heart failure and cardiomyopathies!

Now out in JACC Journals jacc.org/doi/epdf/10.10…; new data on health status in #DELIVER ! Dapa improves #KCCQ across all clinically relevant domains. A pleasure to write this with scottdavidsolomon Mikhail Kosiborod Muthu Vaduganathan and team! See delivertrial.org for more!

Can we reverse diabetes with weightloss? Matthew MY Lee #CVCT2022 Young Triallist Fellow from University of Glasgow Heart Failure Research Group summarizes results of DIRECT trial- first study to show remission of diabetes with diet and weightloss

In case you missed them - 2 new articles in JAMA Cardiology from the group and colleagues:

SGLT2 Inhibitors for HFpEF in the US ja.ma/3gybPii

Dapagliflozin and Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection ja.ma/3AFCIaJ

Very interesting work presented at #AHA2022 by Leanne Mooney and Ninian Lang reporting the prevalence of clonal hematopoiesis of indeterminate potential (CHIP)in patients admitted to hospital with HF.

CHIP was associated with inflammation, in particular IL-1 Beta

Great work led by Mingming Yang highlighting the independent benefit of dapagliflozin in patients with HFmrEF and HFpEF - presented today at #AHA22 and online in European Society of Cardiology Journals #EJHF

Fantastic to see the results of IRONMAN published now in The Lancet

Many hours of hard work from the UK team including Mark Petrie Ninian Lang and many more

thelancet.com/journals/lance…